Advertisement

Topics

Midatech Ltd. Company Profile

08:53 EST 12th December 2018 | BioPortfolio

Midatech Ltd, UK, is a world leader in the design, synthesis and manufacture of biocompatible nanoparticles. These nanoparticles can be used to create a wide variety of products with novel characteristics, functions and applications for a number of industry segments including life sciences, electronics and fine chemicals.


News Articles [42 Associated News Articles listed on BioPortfolio]

Midatech Announces Proposed Sale of Midatech Pharma US Inc. (“MTP US”) to Kanwa Holdings, LP an affiliate of Barings LLC

27 September 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech Announces Proposed Sale of Midatech Pharma US Inc. (“MTP US”) to Kanwa Holdings, LP an affiliate of Barings LLC T...

Midatech Pharma to co-promote Bausch Health's NeutraSal in the US

Bausch Health Companies Inc. (formerly Valeant) is licensing Midatech Pharma PLC’s Midatech Pharma US Inc. subsidiary exclusive rights to promote its supersaturated calcium product NeutraSal rinse i...

Zak Mir: Midatech Pharma looking upwards if it breaks 50-day trend

Midatech Pharma Inc (LON:MTPH) can look towards 118p if it can break through the 50-day moving average suggests technical analyst Zak Mir.

New loan for Midatech promises greater profitability

Midatech Pharma Plc (LON:MTPH, NASDAQMTP) boss tells us how the company has secured a US$15mln, four-year senior loan facility that will be used to bankroll the clinical development of two promising...

Midatech: The Story of a Nanoparticle Start-Up

In this exclusive interview, Fintan Walton talks to Tom Rademacher, President of Midatech, about the formation of the biotech, Professor Rademacher's fifth start-up company. Tom discusses Midatech's b...

Midatech Pharma “delighted” with first in-human data for MTD201 drug

While the data bodes well for MTD201, Midatech is most excited by the validation of its Q-Sphera sustained release technology, which it is using in some of its other compounds

Midatech Pharma “delighted” with first-in-human data for MTD201 drug

While the data bodes well for MTD201, Midatech is most excited by the validation of its Q-Sphera sustained release technology, which it is using in some of its other compounds

Midatech making “significant progress” with two of its key clinical programmes

Early data from the first in-human study of Midatech’s acromegaly and carcinoid cancer drug, MTD201 is due within the next few months, while its, MTX110 brain cancer treatment continues to “progre...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Midatech Ltd.

Midatech Ltd, UK, is a world leader in the design, synthesis and manufacture of biocompatible nanoparticles. These nanoparticles can be used to create a wide variety of products w...

Midatech Group Ltd.

Midatech Ltd, UK, is a world leader in the design, synthesis and manufacture of biocompatible nanoparticles. These nanoparticles can be used to create a wide variety of products with novel character...

More Information about "Midatech Ltd." on BioPortfolio

We have published hundreds of Midatech Ltd. news stories on BioPortfolio along with dozens of Midatech Ltd. Clinical Trials and PubMed Articles about Midatech Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Midatech Ltd. Companies in our database. You can also find out about relevant Midatech Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record